ACTU

Actuate Therapeutics Inc NASDAQ Listed Aug 13, 2024

Healthcare ·Biotechnology ·US · actuatetherapeutics.com

$3.34

Mkt Cap $79.2M

52w Low $1.58 16.9% of range 52w High $11.99

50d MA $2.65 200d MA $5.66

P/E (TTM) -2.8x

EV/EBITDA -5.2x

P/B 8.0x

Debt/Equity 0.1x

ROE -280.5%

P/FCF -6.7x

RSI (14) —

ATR (14) —

Beta 0.86

50d MA $2.65

200d MA $5.66

Avg Volume 118.7K

Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of cancers. The company's lead product candidate is Elraglusib Injection, a novel glycogen synthase kinase-3 inhibitor to treat metastatic pancreatic ductal adenocarcinoma. It also develops Elraglusib for the treatment of Ewing sarcoma, metastatic melanoma, and colorectal cancer. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015. The company was incorporated in 2015 and is based in Fort Worth, Texas.

CIK (SEC)

1652935

Phone

817 887 8455

1751 River Run · Fort Worth, TX 76107 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 26, 2026	AMC	-0.24	-0.18	+25.0%	2.27	-0.9%	-5.3%	+0.9%	+20.7%	+9.7%	+9.3%	—
Nov 13, 2025	AMC	-0.27	-0.25	+7.4%	5.88	+0.5%	+0.5%	+0.7%	+3.7%	-0.5%	+3.6%	—
Aug 14, 2025	AMC	-0.19	-0.30	-57.9%	8.22	-2.9%	-1.2%	+0.4%	-3.0%	-6.6%	-6.7%	—
May 15, 2025	AMC	-0.30	-0.32	-6.7%	9.76	+0.3%	+8.1%	+5.1%	+8.6%	+12.5%	+3.5%	—
Mar 13, 2025	AMC	-0.29	-0.33	-13.8%	7.45	-1.6%	-2.7%	-0.7%	+0.1%	-1.3%	-6.2%	—
Nov 13, 2024	AMC	-0.55	-0.55	+0.0%	8.56	+2.0%	-0.1%	+1.4%	+4.7%	+4.0%	+0.2%	—
Sep 24, 2024	AMC	—	-4.20	—	6.52	+0.0%	-11.0%	-6.9%	-3.8%	+14.3%	+6.1%	—
Mar 31, 2024	AMC	—	-0.54	—	—	—	—	—	—	—	—	—
Dec 31, 2023	AMC	—	-0.50	—	—	—	—	—	—	—	—	—
Sep 30, 2023	AMC	—	-0.41	—	—	—	—	—	—	—	—	—
Jun 30, 2023	AMC	—	-0.39	—	—	—	—	—	—	—	—	—
Mar 31, 2023	AMC	—	-0.39	—	—	—	—	—	—	—	—	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 22	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.27	$2.38	+4.8%	+22.5%	+11.5%	+30.8%	+25.6%	+27.8%
Apr 13	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.72	$1.72	+0.0%	+5.8%	+20.9%	+25.0%	+25.0%	+34.3%
Nov 19	HC Wainwright & Co.	Maintains	Buy → Buy	—	$6.10	$5.95	-2.5%	-4.1%	-0.2%	+3.4%	+2.6%	+2.5%
Sep 23	HC Wainwright & Co.	Maintains	Buy → Buy	—	$7.09	$7.19	+1.4%	-3.0%	-1.0%	-6.2%	-2.8%	-4.5%
Aug 18	HC Wainwright & Co.	Maintains	Buy → Buy	—	$8.12	$8.12	+0.0%	+1.6%	-1.8%	-5.4%	-5.5%	+3.0%

Data updated apr 24, 2026 10:44am · Source: massive.com